EquiSeq Featured in Albuquerque Journal

ALBUQUERQUE, NEW MEXICO – January 11, 2026 EquiSeq was profiled in the Business section of the Albuquerque Journal on January 11, 2026. The article, by writer Hannah Garcia, described the company’s origins and the road ahead, based on interviews with Paul Szauter, Chief Scientific Officer; Madison Sanders, an equestrian who is a member of EquiSeq’s…

Read More

EquiSeq Announces Issuance of Second U.S. Patent to Detect Muscle Disease in Horses

ALBUQUERQUE, New Mexico – December 16, 2025 – EquiSeq Inc, a biotechnology company developing DNA tests for inherited muscle disease in horses, announced today that the United States Patent and Trademark Office has issued U.S. Patent Number 16/088,247, “Method of Detecting Inherited Equine Myopathy.” The patent includes claims covering specific genetic mutations that predispose to muscle disease…

Read More

EquiSeq Holds First Webinar

ALBUQUERQUE, NEW MEXICO – November 13, 2025 EquiSeq held its first Decoding Horse Health webinar on Zoom on November 11, 2025. Madison Sanders (Elite Equine Marketplace and EquiSeq) interviewed Paul Szauter, PhD (EquiSeq’s Chief Scientific Officer) and Stephanie Carter, FNTP (Indigo Ancestral Health). The webinar focused on inherited muscle disease in horses. Dr. Szauter discussed…

Read More

EquiSeq’s DNA Test Changes the Landscape

ALBUQUERQUE, NEW MEXICO – October 14, 2025 The October 2025 issue of Equine Business Magazine published an article on EquiSeq, describing its DNA test as changing the landscape in managing horse health. Madison Ruddy Sanders, founder of Elete Equine Marketplace and a member of EquiSeq’s Board of Directors, wrote the article, based on conversations with…

Read More

EquiSeq Announces Issuance of U.S. Patent to Detect Genetic Variants Causing Muscle Disease in Horses

Veterinarian with a horse

ALBUQUERQUE, New Mexico – September 2, 2025 – EquiSeq Inc, a biotechnology company developing DNA tests for inherited muscle disease in horses, announced today that the United States Patent and Trademark Office has issued U.S. Patent Number 12,398,426, “Methods of Detecting Inherited Myopathies in Horses.” The patent includes claims covering specific genetic mutations that predispose to muscle…

Read More

Experienced Equestrian Joins EquiSeq Board

Albuquerque, New Mexico, USA June 20, 2025 EquiSeq, a leader in developing genetic tests for horses, is pleased to announce the appointment of Madison R. Sanders to its Board of Directors, effective immediately. Ms. Sanders is an experienced equestrian with a proven track record in sales and marketing. She is a lifelong hunter/jumper equestrian and…

Read More

Science Team Meets to Discuss Projects

Four members of EquiSeq’s Scientific Advisory Board. Left to right: David Nannemann, Paul Szauter, Jesse Young, and Jeremy Edwards. Four members of EquiSeq’s Scientific Advisory Board met on June 2 to get acquainted and to discuss ongoing research projects. Science team members Jeremy Edwards (University of New Mexico), Jesse Young (TriCore Reference Laboratories), David Nannemann…

Read More

Twenty European countries issue patent on EquiSeq DNA tests

ALBUQUERQUE, NEW MEXICO EquiSeq announced today that a group of twenty countries in Europe have issued a patent on EquiSeq’s DNA test for three genetic variants that predispose to muscle disease. The tests are part of EquiSeq’s current DNA panel. Test results allow horse owners to better manage affected horses, and can be used to…

Read More

Jeremy Edwards speaks on intellectual property

Jeremy Edwards, Chair of Department of Chemistry and Chemical Biology at the University of New Mexico, is one of UNM’s most prolific inventors. Dr. Edwards is part of the EquiSeq science team and is an inventor on two of EquiSeq’s patents. In this interview, Dr. Edwards talks about the importance of protecting intellectual property.

Read More

South Africa issues patent on EquiSeq DNA tests

ALBUQUERQUE, NEW MEXICO EquiSeq announced today that South Africa has issued a patent on EquiSeq’s DNA tests for three genetic variants in horses that predispose to muscle disease. The tests are part of EquiSeq’s current DNA panel. Test results allow horse owners to better manage affected horses, and can be used to improve a breeding…

Read More